← Leaderboards
Benjamin George Keselowsky
University Of Florida
$10,555,340
Attributed
$15,451,286
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,451,286 · 11
By mechanism
R01$12,762,857 · 6
T32$1,718,646 · 1
R21$797,670 · 2
R56$162,113 · 1
R13$10,000 · 1
Top collaborators
- Mark A Atkinson14 shared
- Dorina Avram8 shared
- Ali Zarrinpar7 shared
- Christine E Schmidt1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Dorina Avram$13,642,871
- Deanna Bousalis$49,540
Research focus
Insulin-Dependent Diabetes MellitusImmuneProgramsCellsInnovationIn VivoPharmaceutical PreparationsAntigensInflammatoryCell TypeDoseInjectableIn VitroTissuesImmune ResponseInflammationT-LymphocyteHomeostasisImmune SystemBasePeptidesEngineeringPhagocytesEncapsulated
Grant awards (48)
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis$740,837
R01 · FY2025 · AI · contact PI
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$569,158
R01 · FY2025 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$192,960
T32 · FY2025 · DK
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$50,490
T32 · FY2025 · DK
2025 Biomaterials and Tissue Engineering Gordon Research Conference and Seminar$10,000
R13 · FY2025 · EB · contact PI
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis$774,914
R01 · FY2024 · AI · contact PI
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$616,580
R01 · FY2024 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$184,007
T32 · FY2024 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$74,969
R01 · FY2024 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$49,881
T32 · FY2024 · DK
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis$798,278
R01 · FY2023 · AI · contact PI
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$654,230
R01 · FY2023 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$162,946
T32 · FY2023 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$115,581
R01 · FY2023 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$47,999
T32 · FY2023 · DK
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$676,374
R01 · FY2022 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$172,063
T32 · FY2022 · DK
Diversity Supplement: Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury$37,510
R01 · FY2022 · DK · contact PI
Tolerogenic dual microparticle system for treatment of multiple sclerosis$520,957
R01 · FY2021 · AI · contact PI
Functionalized Enzyme Treatments for Dual-Targeting of Inflammation in Spinal Cord Injury$410,030
R21 · FY2021 · NS
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$174,832
T32 · FY2021 · DK
Tolerogenic dual microparticle system for treatment of multiple sclerosis$520,957
R01 · FY2020 · AI · contact PI
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses$464,175
R01 · FY2020 · DE · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$93,836
T32 · FY2020 · DK
Tolerogenic dual microparticle system for treatment of multiple sclerosis$520,957
R01 · FY2019 · AI · contact PI
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses$464,175
R01 · FY2019 · DE · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$170,425
T32 · FY2019 · DK
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$42,606
T32 · FY2019 · DK
Tolerogenic dual microparticle system for treatment of multiple sclerosis$520,957
R01 · FY2018 · AI · contact PI
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses$468,522
R01 · FY2018 · DE · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$168,300
T32 · FY2018 · DK
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$42,075
T32 · FY2018 · DK
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses$567,817
R01 · FY2017 · DE · contact PI
Tolerogenic dual microparticle system for treatment of multiple sclerosis$520,957
R01 · FY2017 · AI · contact PI
Biomaterial Delivery System for Type 1 Diabetes Vaccine$374,186
R01 · FY2017 · DK · contact PI
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering$166,226
T32 · FY2017 · DK
Biomaterial Delivery System for Type 1 Diabetes Vaccine$374,186
R01 · FY2016 · DK · contact PI
Dendritic Cell-Targeting Microparticles for Subcellularly-Targeted Delivery of In$316,246
R01 · FY2016 · DK · contact PI
Biomaterial Delivery System for Type 1 Diabetes Vaccine$374,186
R01 · FY2015 · DK · contact PI
Dendritic Cell-Targeting Microparticles for Subcellularly-Targeted Delivery of In$327,409
R01 · FY2015 · DK · contact PI
Biomaterial Delivery System for Type 1 Diabetes Vaccine$374,186
R01 · FY2014 · DK · contact PI
Dendritic Cell-Targeting Microparticles for Subcellularly-Targeted Delivery of In$350,176
R01 · FY2014 · DK · contact PI
Dendritic Cell-Targeting Microparticles for Subcellularly-Targeted Delivery of In$306,512
R01 · FY2013 · DK · contact PI
High-Throughput Evaluation of Dendritic Cell-Targeting Vaccine Particles for the$169,395
R21 · FY2013 · AI · contact PI
Dendritic Cell-Targeting Microparticles for Subcellularly-Targeted Delivery of In$20,684
R01 · FY2013 · DK · contact PI
Delivery of Insulin Peptide, Vitamin D3, TGF-b1 & GM-CSF in Type-1 Diabetes$317,181
R01 · FY2012 · DK · contact PI
High-Throughput Evaluation of Dendritic Cell-Targeting Vaccine Particles for the$218,245
R21 · FY2012 · AI · contact PI
Dendritic Cell-Targeting Microparticles for Subcellularly-Targeted Delivery of Vi$162,113
R56 · FY2011 · DK · contact PI